{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:43:42Z","timestamp":1793720622509,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shanghai Science and Technology Committee Rising-Star Program","award":["24YF2725100"],"award-info":[{"award-number":["24YF2725100"]}]},{"name":"the Science and Technology Commission of Shanghai Municipal Jiading District","award":["JDKW-2023-0021"],"award-info":[{"award-number":["JDKW-2023-0021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03347-x","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:50:33Z","timestamp":1759315833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Spontaneous pneumomediastinum and\/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiajia","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"9","key":"3347_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","volume":"17","author":"A Selva-O\u2019Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018;17(9):816\u201328.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3347_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W, Guo L, Fu Y, Wang K, Zhang D, Xu W, et al. Interstitial lung disease in anti-MDA5 positive dermatomyositis. Clinic Rev Allerg Immunol. 2021;60(2):293\u2013304.","journal-title":"Clinic Rev Allerg Immunol"},{"issue":"1","key":"3347_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/rheumatology\/keab305","volume":"61","author":"W Wu","year":"2021","unstructured":"Wu W, Xu W, Sun W, Zhang D, Zhao J, Luo Q, et al. Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study. Rheumatology. 2021;61(1):230\u20139.","journal-title":"Rheumatology"},{"key":"3347_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.768052","volume":"8","author":"W Xu","year":"2021","unstructured":"Xu W, Wu W, Zheng Y, Chen Z, Tao X, Zhang D, et al. A computed tomography radiomics-based prediction model on interstitial lung disease in anti-MDA5-positive dermatomyositis. Front Med. 2021;8:768052.","journal-title":"Front Med"},{"issue":"1","key":"3347_CR5","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1038\/s41598-021-96292-w","volume":"11","author":"W Xu","year":"2021","unstructured":"Xu W, Wu W, Zhang D, Chen Z, Tao X, Zhao J, et al. A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis. Sci Rep. 2021;11(1):17070.","journal-title":"Sci Rep"},{"issue":"3","key":"3347_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, et al. Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, Tacrolimus, and Cyclophosphamide in interstitial lung diseases accompanied by anti-Melanoma Differentiation\u2013Associated gene 5\u2013positive dermatomyositis. Arthritis Rheumatol. 2020;72(3):488\u201398.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3347_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang X, Ye S. Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. N Engl J Med. 2019;381(3):291\u20133.","journal-title":"N Engl J Med"},{"issue":"4","key":"3347_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.reumae.2024.04.002","volume":"20","author":"P Arango Guerra","year":"2024","unstructured":"Arango Guerra P, Monsalve Yepes S, Chavarriaga Restrepo A, Velasquez Franco CJ. Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 cases. Reumatolog\u00eda Cl\u00ednica (English Edition). 2024;20(4):218\u201322.","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)."},{"issue":"12","key":"3347_CR9","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1007\/s10067-019-04729-5","volume":"38","author":"K Yamaguchi","year":"2019","unstructured":"Yamaguchi K, Yamaguchi A, Itai M, Kashiwagi C, Takehara K, Aoki S, et al. Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum. Clin Rheumatol. 2019;38(12):3443\u201350.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"3347_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1378\/chest.104.1.44","volume":"104","author":"T Fujiwara","year":"1993","unstructured":"Fujiwara T. Pneumomediastinum in pulmonary fibrosis. Chest. 1993;104(1):44\u20136.","journal-title":"Chest"},{"issue":"1","key":"3347_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002770","volume":"9","author":"K Abe","year":"2023","unstructured":"Abe K, Furuta S, Kobayashi Y, Sugiyama T, Kagami SI, Nakagomi D, et al. Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD Open. 2023;9(1):e002770.","journal-title":"RMD Open"},{"key":"3347_CR12","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.2147\/JIR.S389839","volume":"16","author":"AH Subki","year":"2023","unstructured":"Subki AH, Almani IM, Albeity A, Aljabri BK, Alsolaimani R, Halabi H. Spontaneous Pneumomediastinum and Subcutaneous Emphysema in Dermatomyositis: A Case Series and Literature Review. JIR. 2023;16:1431\u201341.","journal-title":"JIR"},{"issue":"2","key":"3347_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5387\/fms.2018-01","volume":"64","author":"M Yashiro","year":"2018","unstructured":"Yashiro M, Asano T, Sato S, Kobayashi H, Watanabe H, Miyata M, et al. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum. Fukushima J Med Sci. 2018;64(2):89\u201394.","journal-title":"Fukushima J Med Sci"},{"key":"3347_CR14","doi-asserted-by":"publisher","unstructured":"Okabayashi H, Nakashima S, Fujino K, et al. Tension Pneumomediastinum in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease: A Case Report and Literature Review. Intern Med. Published online 2024:3418\u20133423. https:\/\/doi.org\/10.2169\/internalmedicine.3418-23","DOI":"10.2169\/internalmedicine.3418-23"},{"key":"3347_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152352","volume":"65","author":"Q Jin","year":"2024","unstructured":"Jin Q, Lin S, Chen X, Xu Y, Tian X, He L, et al. Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: prevalence, risk factors, and prognosis. Semin Arthritis Rheum. 2024;65:152352.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"3347_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis: (first of two parts). N Engl J Med. 1975;292(7):344\u20137.","journal-title":"N Engl J Med"},{"issue":"8","key":"3347_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis: (second of two parts). N Engl J Med. 1975;292(8):403\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"3347_CR18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46(4):626\u201336.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3347_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen AL, Allenbach Y, Stenzel W, Benveniste O, Allenbach Y, Benveniste O, et al. 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 december 2018. Neuromuscul Disord. 2020;30(1):70\u201392.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"3347_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000029539","volume":"67","author":"T Kaneki","year":"2000","unstructured":"Kaneki T, Kubo K, Kawashima A, Koizumi T, Sekiguchi M, Sone S. Spontaneous pneumomediastinum in 33 patients: yield of chest computed tomography for the diagnosis of the mild type. Respiration. 2000;67(4):408\u201311.","journal-title":"Respiration"},{"key":"3347_CR21","doi-asserted-by":"publisher","first-page":"2401488","DOI":"10.1183\/13993003.01488-2024","volume":"30","author":"W Wu","year":"2025","unstructured":"Wu W, Guo B, Sun W, Chen D, Xu W, Chen Z, et al. Effectiveness and safety of tofacitinib versus calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multi-centre cohort study. Eur Respir J. 2025;30:2401488.","journal-title":"Eur Respir J"},{"issue":"1","key":"3347_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","volume":"47","author":"DW Denning","year":"2016","unstructured":"Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47(1):45\u201368.","journal-title":"Eur Respir J"},{"issue":"Suppl3","key":"3347_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.37201\/req\/s03.16.2022","volume":"35","author":"V Garc\u00eda-Bustos","year":"2022","unstructured":"Garc\u00eda-Bustos V, Salavert M, Blanes R, Caba\u00f1ero D, Blanes M. Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies. Rev Esp Quimioter. 2022;35(Suppl3):74\u20139.","journal-title":"Rev Esp Quimioter"},{"issue":"6","key":"3347_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab248","volume":"8","author":"J Bruminhent","year":"2021","unstructured":"Bruminhent J, Autto S, Rotjanapan P, Ngarmjanyaporn P, Bushyakanist A, Kirdlarp S, et al. A prospective study of cytomegalovirus-specific cell-mediated immune monitoring and cytomegalovirus infection in patients with active systemic lupus erythematosus receiving immunosuppressants. Open Forum Infect Dis. 2021;8(6):ofab248.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"3347_CR25","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1093\/rheumatology\/keaa582","volume":"60","author":"C Li","year":"2021","unstructured":"Li C, Liang M, Jiang H, Zhao J, Wu C, Wang Q, et al. The long-term prognosis of pneumomediastinum associated with dermatomyositis: a two-centre retrospective cohort study. Rheumatology. 2021;60(5):2288\u201395.","journal-title":"Rheumatology"},{"issue":"1","key":"3347_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/14397595.2017.1318468","volume":"28","author":"Y Fujiki","year":"2018","unstructured":"Fujiki Y, Kotani T, Isoda K, Ishida T, Shoda T, Yoshida S, et al. Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients. Mod Rheumatol. 2018;28(1):133\u201340.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"3347_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-017-1506-7","volume":"20","author":"Y Sugiyama","year":"2018","unstructured":"Sugiyama Y, Yoshimi R, Tamura M, Takeno M, Kunishita Y, Kishimoto D, et al. The predictive prognostic factors for polymyositis\/dermatomyositis-associated interstitial lung disease. Arthritis Res Ther. 2018;20(1):7.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3347_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","volume":"158","author":"X Lian","year":"2020","unstructured":"Lian X, Zou J, Guo Q, Chen S, Lu L, Wang R, et al. Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease. Chest. 2020;158(4):1535\u201345.","journal-title":"Chest"},{"key":"3347_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.808875","volume":"8","author":"X Lv","year":"2022","unstructured":"Lv X, Jin Y, Zhang D, Li Y, Fu Y, Wang S, et al. Low circulating monocytes is in parallel with lymphopenia which predicts poor outcome in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease. Front Med. 2022;8:808875.","journal-title":"Front Med"},{"issue":"5","key":"3347_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/mr\/roac091","volume":"33","author":"S He","year":"2023","unstructured":"He S, Zhou Y, Fan C, Ma J, Chen Y, Wu W, et al. Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis. Mod Rheumatol. 2023;33(5):975\u201381.","journal-title":"Mod Rheumatol"},{"key":"3347_CR31","doi-asserted-by":"crossref","unstructured":"Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23). Available from:\u00a0http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2012.5669. Cited 2025 Aug 11.","DOI":"10.1001\/jama.2012.5669"},{"issue":"1","key":"3347_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/art.24372","volume":"61","author":"B Le Goff","year":"2008","unstructured":"Le Goff B, Ch\u00e9rin P, Cantagrel A, Gayraud M, Hachulla E, Laborde F, et al. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. Arthritis Rheum. 2008;61(1):108\u201318.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3347_CR33","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s10067-019-04918-2","volume":"39","author":"M Zhou","year":"2020","unstructured":"Zhou M, Ye Y, Yan N, Lian X, Bao C, Guo Q. Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis. Clin Rheumatol. 2020;39(6):1919\u201327.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"3347_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/ard.59.5.372","volume":"59","author":"H Kono","year":"2000","unstructured":"Kono H. Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy. Ann Rheum Dis. 2000;59(5):372\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3347_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12890-019-1016-2","volume":"19","author":"J Xia","year":"2019","unstructured":"Xia J, Gu S, Li M, Liu D, Huang X, Yi L, et al. Spontaneous breathing in patients with severe acute respiratory distress syndrome receiving prolonged extracorporeal membrane oxygenation. BMC Pulm Med. 2019;19(1):237.","journal-title":"BMC Pulm Med"},{"issue":"18","key":"3347_CR36","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.2169\/internalmedicine.6892-20","volume":"60","author":"S Okamoto","year":"2021","unstructured":"Okamoto S, Tsuboi H, Noma H, Tabuchi D, Sugita T, Nishiyama T, et al. Predictive factors for pneumomediastinum during management of connective tissue disease-related interstitial lung disease: a retrospective study. Intern Med. 2021;60(18):2887\u201397.","journal-title":"Intern Med"},{"issue":"9","key":"3347_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00296-008-0548-1","volume":"28","author":"K Yoshida","year":"2008","unstructured":"Yoshida K, Kurosaka D, Kingetsu I, Hirai K, Yamada A. Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature. Rheumatol Int. 2008;28(9):913\u20137.","journal-title":"Rheumatol Int"},{"key":"3347_CR38","doi-asserted-by":"publisher","first-page":"1286973","DOI":"10.3389\/fimmu.2024.1286973","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Lv C, You H, Xu L, Yuan F, Li J, et al. Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model. Front Immunol. 2024;15:1286973.","journal-title":"Front Immunol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03347-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03347-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03347-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:50:36Z","timestamp":1759315836000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03347-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3347"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03347-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with Good Clinical Practice, including the Declaration of Helsinki. The study protocol and informed consent form was approved by the Ethics Committees of Renji Hospital (approval number: LY2023-284-C). All patients provided written informed consent before screening.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}